Faculty
Oncology Division
Alphabetical list (active faculty):   
Kiran R. Vij

Kiran R. Vij, MD

Associate Professor

Department of Medicine

Oncology Division

Bone Marrow Transplantation & Leukemia

Department of Pathology & Immunology

Clinical Interests

  • Hematopathology

Contact

  • 314-454-7425 (office)
  • 314-454-7551 (fax)
  • Division of Oncology
    Campus Box 8056
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 11th Floor Mid-Campus Center (office)

Research

I hold a joint appointment in both the Division of Medical Oncology (Department of Medicine) and Division of Surgical Pathology (Department of Pathology/Immunology). Having fellowship training in hematopathology, clinical cytogenetics and surgical pathology, I have service commitments in hematopathology and gynaecologic pathology.

I oversee training of pathology residents and heme-path and surgical pathology fellows in training. I am also responsible for a didactic curriculum and providing basic training in hematopathology for clinical fellows and residents in medical oncology and hematology.

I work closely with clinicians and basic science researchers in Medical Oncology to further translational research projects in malignant hematology utilizing my skills in hematopathology and cytogenetics. These include serving as site pathologist for the multi-institutional Lymphoma Epidemiology of Outcomes (LEO) cohort study to support a broad research agenda aimed at identifying novel, clinical, epidemiologic, host genetic, tumor, and treatment factors that significantly influence NHL prognosis and survivorship. I am a co-investigator on the Specialized Program Of Research Excellence (SPORE) in Leukemia on studies that test novel approaches to develop biomarkers with a long term goal to treat patients with acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndromes.

I serve as the pathologist for several multicenter clinical trials studying the pathologic and clinical efficacy of neoadjuvant therapies in breast cancer and also in basic science studies involving murine models of graft versus host disease (GVHD).